FILE:BAX/BAX-8K-20101012163533.txt.gz
EVENTS:	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers	Other Events
TEXT:
ITEM: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM: Other Events
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (General Instruction A.2. below):
see
 
 
 
     On October 12, 2010, Baxter International Inc. (the "") announced the resignation of Joy A. Amundson from her position as Corporate Vice President and President, BioScience. The Company also announced the resignation of Peter J. Arduini from his position as Corporate Vice President and President, Medication Delivery, his employment to end effective as of October 29, 2010. Mr. Arduini will be paid a lump sum cash payment in the amount of $250,000 to reflect transition services and to recognize his performance and contributions in 2010.
Company
     On October 12, 2010, the Company announced that it has combined the Company's Medication Delivery and Renal businesses into one global business unit, Medical Products. Robert M. Davis, currently the Company's Corporate Vice President and President, Renal, has been appointed to serve as Corporate Vice President and President, Medical Products, and Ludwig N. Hantson, currently the Company's Corporate Vice President and President, International, has been appointed to serve as Corporate Vice President and President, BioScience.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
Date: October 12, 2010


